Group One Trading
AUTL

Group One Trading’s Autolus Therapeutics AUTL Stock Holding History

Group One Trading’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,381
Closed -$12.9K – 8109
2025
Q3 		$13.7K Buy
+8,381
New +$16.4K ﹤0.01% 6977
2023
Q1 		– Sell
-2,700
Closed -$5.28K – 7186
2022
Q4 		$5.13K Sell
2,700
-3,200
-54% -$8.09K ﹤0.01% 6338
2022
Q3 		$13K Hold
5,900
– – ﹤0.01% 6322
2022
Q2 		$17K Buy
5,900
+100
+2% +$304 ﹤0.01% 6393
2022
Q1 		$24K Buy
5,800
+2,000
+53% +$8.41K ﹤0.01% 6632
2021
Q4 		$20K Buy
3,800
+1,700
+81% +$10.2K ﹤0.01% 6976
2021
Q3 		$14K Buy
+2,100
New +$13.3K ﹤0.01% 7335

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Group One Trading's AUTL Position: Q4 2025 in Review

Group One Trading sold out of Autolus Therapeutics (AUTL) in Q4 2025, closing a stake of 8,381 shares — an estimated $12.9K sold.

Group One Trading first reported a position in AUTL in Q3 2021 and held it in 7 quarters. The position peaked at $24K in Q1 2022. 89 funds tracked by Wall St. Rank hold AUTL as of Q4 2025.

  • Group One Trading reported no remaining Autolus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 8,381 Autolus Therapeutics shares in Q4 2025, an estimated $12.9K.
  • Group One Trading first reported a position in Autolus Therapeutics in Q3 2021 and held it in 7 quarters.
  • Group One Trading's Autolus Therapeutics position peaked at $24K in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.